Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/14265
Title: | Antiproliferative effect of α-mangostin on canine osteosarcoma cells |
Authors: | Krajarng A. Nilwarankoon S. Suksamrarn S. Watanapokasin R. |
Keywords: | alpha mangostin antineoplastic agent DNA hoe 33342 phosphatidylserine unclassified drug xanthone derivative animal cell antiproliferative activity apoptosis article cell cycle G1 phase cell membrane cell nucleus fragmentation cell strain D 17 cellular parameters concentration response controlled study DNA fragmentation dog drug cytotoxicity drug isolation flow cytometry Garcinia mangostana gel electrophoresis IC 50 mitochondrial membrane potential nonhuman nuclear condensation nucleosome osteosarcoma osteosarcoma cell pericarp phospholipid metabolism staining Animals Antineoplastic Agents, Phytogenic Cell Cycle Cell Line, Tumor Cell Proliferation Cell Survival Dogs Garcinia mangostana Osteosarcoma Xanthones Canis familiaris Garcinia mangostana |
Issue Date: | 2012 |
Abstract: | Osteosarcoma is the most frequently diagnosed primary bone tumor in dog. Since chemotherapeutics are quite limited due to high cost and severe toxicity, therefore, the ultimate goal is to discover cost-effective therapeutics with less toxicity. We have studied the effect of α-mangostin, a xanthone derivative isolated from pericarp of mangosteen (Garcinia mangostana Linn.) in canine osteosarcoma, D-17 cells. The results showed that α-mangostin induced antiproliferation with IC50 at 15μg/ml. Hoechst 33342 nuclear staining and nucleosomal DNA-gel electrophoresis revealed that α-mangostin could induce nuclear condensation and fragmentation, typically seen in apoptosis. Cell cycle analysis demonstrated that α-mangostin induced sub-G1 peak. In addition, α-mangostin also induced membrane flipping of the phosphatidylserine and the loss of mitochondrial membrane potential in D-17 cells. In conclusion, α-mangostin, induced apoptotic cell death against canine osteosarcoma D-17 cells, could be a potential candidate for preventive and therapeutic application for bone cancer treatment in dogs. © 2012 Elsevier Ltd. |
URI: | https://ir.swu.ac.th/jspui/handle/123456789/14265 https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863108518&doi=10.1016%2fj.rvsc.2012.01.015&partnerID=40&md5=5ce11b57663ec1f4cc4b389c5adeb1ce |
ISSN: | 345288 |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.